CCN4 and breast cancer: Several clinical studies have indicated a significant association between WISP1 polymorphisms and various cancers, such as breast cancer [14], urothelial cell carcinoma [15], hepatocellular carcinoma [16], oral squamous cell carcinoma [17], lung cancer [18] and uterine cervical cancer [19].